🇫🇷 France / CC-FR-2608-02

France SAS for biotech R&D · NAF 72.11Z

Illustrative current-month SAS for biotech R&D; permissions, laboratory setup and IP are reviewed separately from the entity purchase.

STATUS
Available for review
REVIEW
Data unverified
INCORPORATED
Aug 01, 2026
HANDOVER INDICATION
5–12 business days after KYC
01

Company profile

NAF/APE describes the principal activity once assigned by INSEE and is not a licence. Corporate documents, UBOs, president, tax position and absence of activity are reviewed before handover.

Legal form
Société par actions simplifiée (SAS)
Jurisdiction
France
Trading history
Not declared / dormant profile
Last updated
Oct 24, 2026
02

Declared activities

NAF / APE 72.11Z
  • Research and development in biotechnology

An activity code describes the intended profile; it does not replace a licence, permit, tax registration or bank approval.

03

Handover scope

Included in the listing

  • 100% of the shares or membership interest after buyer KYC
  • Registration and constitutional document pack
  • Ownership-transfer and officer-change resolutions
  • Update of available registry details and activity code
  • Good-standing / declared no-trading-history review
  • Handover coordination and an initial banking/KYB pack

Not automatically included

  • Approval by a bank, EMI, acquirer or marketplace
  • Licences, VAT and sector permits unless expressly listed
  • Accounting after handover and the buyer's taxes
04

Governance and transfer routes

Transfer to the client

Ownership, control and UBO records are updated under the applicable procedure after KYC and document review.

Local director

Availability, authority, remuneration and substance requirements are confirmed only after a legal review of the specific structure.

05

Checks before engagement

Before an engagement is confirmed, CrystalCore rechecks:

  • existence, status and seller authority
  • corporate records and declared trading history
  • buyer, UBO, source of funds and business purpose
  • tax, filings, licences and the applicable transfer route
06

Reference sources

These links help verify the general procedure. They do not prove that an illustrative entry exists and do not replace a current registry extract or due diligence.